Mar 28, 2017 at 09:29 | Source: Moneycontrol.com
The company has received United States Food and Drug Administration (USFDA) approval for cancer drug Zejula Capsules, for Tesaro Inc.
Mar 27, 2017 at 13:05 | Source: Reuters
Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and the regulatory green light boosts the British drugmaker's prospects in a key therapy area.
Mar 24, 2017 at 16:33 | Source: PTI
A safe and effective drug to reverse ageing and treat cancer may be available in just three years, thanks to scientists who have identified a critical step in how cells repair damaged DNA.
Mar 03, 2017 at 13:59 | Source: Moneycontrol.com
The court allowed the firm to make and sell Canmab, a cancer drug of the company. Stock was under pressure so far on the back of inspection reports. The management, earlier this morning, stated the inspections were expected as its dossiers were accepted by US FDA and EMA.
Mar 02, 2017 at 19:00 | Source: PTI
"Once the designated authority has given approval, you cannot say prima facie you have case over that. Till that (approval) is disturbed by an order of the court, it will remain," a bench of justices Badar Durrez Ahmed and Sanjeev Sachdeva said.
Feb 28, 2017 at 14:36 | Source: CNBC-TV18
"Our priority is to fix the prices of drugs as soon as possible. We do get complaints and representations on the excessively high prices of other drugs", Bhupendra Singh, Chairman of NPPA told CNBC-TV18.
Feb 28, 2017 at 11:24 | Source: PTI
The approved product is indicated for cleansing of the colon in preparation of colonoscopy in adults. Suprep Bowel Prep Kit had US sales of USD 207.2 million.
Feb 22, 2017 at 20:38 | Source: PTI
The Delhi High Court today told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the rest of its life after having enjoyed the fruits of its patent.
Feb 17, 2017 at 09:51 | Source: CNBC-TV18
Biocon Thursday announced the US Food and Drug Administration has accepted Mylans Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and Managing Director Kiran Mazumdar Shaw said, "This is a very important acceptance."
Feb 08, 2017 at 18:00 | Source: Moneycontrol.com
The drug makers much anticipated launch of key blood cancer treatment drug imatinib mesylate in US is facing the risk of further delay, as a partner which the company contracted to supply the drug has hit regulatory compliance hurdle.